Skip to content

Amlodipine besilate

Amlodipine Besylate, Norvasc (amlodipine besylate) is a small molecule pharmaceutical. Amlodipine besylate was first approved as Amlodipine Besylate on 1992-07-31. It is used to treat coronary artery disease, hypertension, and variant angina pectoris in the USA. It is known to target voltage-dependent L-type calcium channel subunit alpha-1D and voltage-dependent L-type calcium channel subunit alpha-1C. Norvasc's patent is valid until 2022-11-20 (FDA).
Trade Name Amlodipine Besylate, Norvasc
Common Name Amlodipine besilate
Indication coronary artery disease, hypertension, variant angina pectoris
Drug Class Phenylpyridine vasodilators (nifedipine type)
Amlodipine besilate
Get full access now